|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
JSTOR_ocn681709571 |
003 |
OCoLC |
005 |
20231005004200.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
101115s2006 ncua ob 001 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d OCLCF
|d NDD
|d YDXCP
|d E7B
|d N$T
|d DEBSZ
|d MHW
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d CUS
|d OCLCO
|d MERUC
|d OCLCO
|d IOG
|d KIJ
|d OCLCA
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d VVB
|d W2U
|d YDX
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d LEAUB
|d CNTRU
|d OCLCQ
|d OCLCO
|d SFB
|d OCLCA
|d VT2
|d OCLCQ
|d JSTOR
|d MM9
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d RDF
|d OCLCO
|d OCLCQ
|d OCL
|
016 |
7 |
|
|a 2005028222
|2 Uk
|
019 |
|
|
|a 220950185
|a 841914283
|a 1027352456
|a 1058368800
|a 1086425688
|a 1119547609
|a 1125485238
|a 1148079548
|a 1167140779
|a 1171210589
|a 1240531464
|a 1245478064
|a 1262689601
|
020 |
|
|
|a 9780822387916
|q (electronic bk.)
|
020 |
|
|
|a 0822387913
|q (electronic bk.)
|
020 |
|
|
|a 0822337290
|
020 |
|
|
|a 9780822337294
|
020 |
|
|
|z 082233741X
|q (pbk. ;
|q alk. paper)
|
020 |
|
|
|z 9780822337416
|q (pbk. ;
|q alk. paper)
|
024 |
3 |
|
|a 9780822337294
|
029 |
1 |
|
|a AU@
|b 000046688244
|
029 |
1 |
|
|a AU@
|b 000052254354
|
029 |
1 |
|
|a AU@
|b 000062463351
|
029 |
1 |
|
|a DEBSZ
|b 397525605
|
029 |
1 |
|
|a NLGGC
|b 36327121X
|
035 |
|
|
|a (OCoLC)681709571
|z (OCoLC)220950185
|z (OCoLC)841914283
|z (OCoLC)1027352456
|z (OCoLC)1058368800
|z (OCoLC)1086425688
|z (OCoLC)1119547609
|z (OCoLC)1125485238
|z (OCoLC)1148079548
|z (OCoLC)1167140779
|z (OCoLC)1171210589
|z (OCoLC)1240531464
|z (OCoLC)1245478064
|z (OCoLC)1262689601
|
037 |
|
|
|b 00008251
|
037 |
|
|
|a 22573/ctv11bvrm7
|b JSTOR
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a HD9665.5
|b .G56 2006
|
060 |
|
4 |
|a QV 736
|b G562 2006
|
072 |
|
7 |
|a BUS
|x 070130
|2 bisacsh
|
072 |
|
7 |
|a BUS
|x 035000
|2 bisacsh
|
072 |
|
7 |
|a BUS
|x 070050
|2 bisacsh
|
082 |
0 |
4 |
|a 338.4/76151
|2 22
|
084 |
|
|
|a 44.02
|2 bcl
|
084 |
|
|
|a F416.7
|2 clc
|
084 |
|
|
|a QR 525
|2 rvk
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Global pharmaceuticals :
|b ethics, markets, practices /
|c edited by Adriana Petryna, Andrew Lakoff, and Arthur Kleinman.
|
260 |
|
|
|a Durham :
|b Duke University Press,
|c 2006.
|
300 |
|
|
|a 1 online resource (301 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references (pages 263-287) and index.
|
505 |
0 |
|
|a Globalizing human subjects research / Adriana Petryna -- The new medical oikumene / David Healy -- Educating for global mental health: the adoption of SSRIs in Japan / Kalman Applbaum -- High contact: gifts and surveillance in Argentina / Andrew Lakoff -- Addiction markets: the case of high-dose buprenorphine in France / Anne M. Lovell -- Pharmaceuticals in urban ecologies: the register of the local / Veena Das and Ranendra K. Das -- Pharmaceutical governance / Joøo Biehl -- Treating AIDS: dilemmas of unequal access in Uganda / Susan Reynolds Whyte, Lotte Meinert, and Betty Kyaddondo.
|
520 |
|
|
|a In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption. Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
546 |
|
|
|a English.
|
590 |
|
|
|a JSTOR
|b Books at JSTOR All Purchased
|
590 |
|
|
|a JSTOR
|b Books at JSTOR Demand Driven Acquisitions (DDA)
|
650 |
|
0 |
|a Pharmaceutical industry.
|
650 |
|
0 |
|a Pharmaceutical industry
|x Marketing.
|
650 |
|
0 |
|a Drugs
|x Marketing
|x Moral and ethical aspects.
|
650 |
|
0 |
|a Pharmaceutical ethics.
|
650 |
|
0 |
|a Commerce.
|
650 |
|
0 |
|a Health services accessibility.
|
650 |
1 |
2 |
|a Drug Industry
|x economics
|
650 |
1 |
2 |
|a Drug Industry
|x ethics
|
650 |
2 |
2 |
|a Commerce
|
650 |
2 |
2 |
|a Health Services Accessibility
|
650 |
2 |
2 |
|a Internationality
|
650 |
2 |
2 |
|a Marketing
|x ethics
|
650 |
2 |
2 |
|a Socioeconomic Factors
|
650 |
|
2 |
|a Drug Industry
|
650 |
|
2 |
|a Ethics, Pharmacy
|
650 |
|
6 |
|a Industrie pharmaceutique.
|
650 |
|
6 |
|a Industrie pharmaceutique
|x Marketing.
|
650 |
|
6 |
|a Médicaments
|x Commercialisation
|x Aspect moral.
|
650 |
|
6 |
|a Pharmaciens
|x Déontologie.
|
650 |
|
6 |
|a Commerce.
|
650 |
|
6 |
|a Services de santé
|x Accessibilité.
|
650 |
|
7 |
|a 44.02 philosophy and ethics of medicine.
|0 (NL-LeOCL)077596218
|2 bcl
|
650 |
|
7 |
|a BUSINESS & ECONOMICS
|x Industries
|x Pharmaceutical & Biotechnology.
|2 bisacsh
|
650 |
|
7 |
|a BUSINESS & ECONOMICS
|x International
|x General.
|2 bisacsh
|
650 |
|
7 |
|a Health services accessibility
|2 fast
|0 (OCoLC)fst00953278
|
650 |
|
7 |
|a Commerce
|2 fast
|0 (OCoLC)fst00869279
|
650 |
|
7 |
|a Drugs
|x Marketing
|x Moral and ethical aspects.
|2 fast
|0 (OCoLC)fst00898841
|
650 |
|
7 |
|a Pharmaceutical ethics.
|2 fast
|0 (OCoLC)fst01060127
|
650 |
|
7 |
|a Pharmaceutical industry.
|2 fast
|0 (OCoLC)fst01060129
|
650 |
|
7 |
|a Pharmaceutical industry
|x Marketing.
|2 fast
|0 (OCoLC)fst01060160
|
650 |
|
7 |
|a Pharmazeutische Industrie
|2 gnd
|
650 |
|
7 |
|a Wirtschaftsethik
|2 gnd
|
650 |
|
7 |
|a Arzneimittelmarkt
|2 gnd
|
650 |
|
7 |
|a Sozialethik
|2 gnd
|
650 |
1 |
7 |
|a Farmaceutische industrie.
|2 gtt
|
650 |
1 |
7 |
|a Marketing.
|2 gtt
|
650 |
1 |
7 |
|a Medische ethiek.
|2 gtt
|
650 |
1 |
7 |
|a Internationalisatie.
|2 gtt
|
700 |
1 |
|
|a Petryna, Adriana,
|d 1966-
|e editor.
|
700 |
1 |
|
|a Lakoff, Andrew,
|d 1970-
|e editor.
|
700 |
1 |
|
|a Kleinman, Arthur,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Global pharmaceuticals.
|d Durham : Duke University Press, 2006
|z 0822337290
|w (DLC) 2005028222
|w (OCoLC)61731434
|
830 |
|
0 |
|a e-Duke books scholarly collection.
|
856 |
4 |
0 |
|u https://jstor.uam.elogim.com/stable/10.2307/j.ctv11cw7qd
|z Texto completo
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10215105
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 599987
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2956937
|
994 |
|
|
|a 92
|b IZTAP
|